Trans-4-Methylcyclohexanamine

• Description :

  Trans-4-Methylcyclohexanamine is an intermediate and can be used for the development of T. cruzi enzyme inhibitor[1].

• UNSPSC :

  12352211

• Hazard Statement :

  H226, H314

• Target :

  Parasite

• Type :

  Reference compound

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/trans-4-methylcyclohexanamine.html

• Concentration :

  10mM

• Purity :

  99.97

• Solubility :

  DMSO : 100 mg/mL (ultrasonic)

• Smiles :

  N[C@H]1CC[C@H](C)CC1

• Molecular Formula :

  C7H15N

• Molecular Weight :

  113.20

• Precautions :

  H226, H314

• References & Citations :

  [1]Melissa F Adasme, et al. Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning. Int J Mol Sci. 2020 Nov 20;21 (22) :8809.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  4°C (Powder, sealed storage, away from moisture and light)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [2523-55-9]